Primary study · included by 1 review

Effect of mixed mutans streptococci colonization on caries development.

Seki 2006 · Seki M, Yamashita Y, Shibata Y, et al. · Oral microbiology and immunology · 2006

PubMed 16390341doi:10.1111/j.1399-302x.2005.00253.xJournal Article; Research Support, Non-U.S. Gov't

Trial PICO

Not extracted yet. Trial-level population, intervention, comparator, outcomes and design will appear here after the trial extraction run. Until then, the reviews below describe the study.

Results

Not extracted yet. Per-trial results (events, means, effect and weight as each review's forest plot reports them) will appear here after the trial extraction run.

Included by

Is Mutans Streptococci count a risk predictor of Early Childhood Caries? A systematic review and meta-analysis.
Non-Cochrane · prognostic · 2023 · cited as Seki 2006 · Reference 18; Fig. 2
Outcome this study informsPooled effectEvidenceCertainty
Development of any (cavitated or non-cavitated) carious lesion
Mutans streptococci present in oral samples at baseline vs Mutans streptococci absent in oral samples at baseline · 6 months to 3.5 years
OR 4.13 [3.33, 5.12]12 studies · 3010 participantsModerate
Development of any (cavitated or non-cavitated) carious lesion
Mutans streptococci present in oral samples at baseline vs Mutans streptococci absent in oral samples at baseline · 6 months to 3.5 years
OR 5.16 [2.99, 8.91]5 studies · 736 participantsUngraded
Development of any (cavitated or non-cavitated) carious lesion
Mutans streptococci present in oral samples at baseline vs Mutans streptococci absent in oral samples at baseline · 6 months to 3.5 years
OR 3.92 [3.20, 4.80]9 studies · 2577 participantsUngraded
Development of any (cavitated or non-cavitated) carious lesion
Mutans streptococci present in oral samples at baseline vs Mutans streptococci absent in oral samples at baseline · 1 year
OR 4.37 [3.50, 5.45]4 studies · 2016 participantsUngraded
Development of any (cavitated or non-cavitated) carious lesion
Mutans streptococci present in oral samples at baseline vs Mutans streptococci absent in oral samples at baseline · 2.7 years (31 months median)
OR 33.00 [3.18, 342.26]1 study · 28 participantsUngraded
Development of any (cavitated or non-cavitated) carious lesion
Mutans streptococci present in oral samples at baseline vs Mutans streptococci absent in oral samples at baseline · 2 years
OR 2.53 [1.22, 5.23]4 studies · 297 participantsUngraded
Development of any (cavitated or non-cavitated) carious lesion
Mutans streptococci present in oral samples at baseline vs Mutans streptococci absent in oral samples at baseline · 6 months to 3.5 years
OR 3.82 [2.01, 7.26]6 studies · 732 participantsUngraded
Development of any (cavitated or non-cavitated) carious lesion
Mutans streptococci present in oral samples at baseline vs Mutans streptococci absent in oral samples at baseline · 3.5 years (42 months)
OR 4.23 [2.49, 7.18]1 study · 366 participantsUngraded
Development of any (cavitated or non-cavitated) carious lesion
Mutans streptococci present in oral samples at baseline vs Mutans streptococci absent in oral samples at baseline · 6 months
OR 4.65 [2.01, 10.76]2 studies · 303 participantsUngraded
Development of any (cavitated or non-cavitated) carious lesion
Mutans streptococci present in oral samples at baseline vs Mutans streptococci absent in oral samples at baseline · 6 months to 3.5 years
OR 4.36 [3.53, 5.39]6 studies · 2278 participantsUngraded

1 including review in total.